Novavax Inc (NVAX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$57.49M
Year ended 2021-12-31
+247.3%
3-year compound annual growth
+25.9%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $57.49M | +5.2% | 2022-03-01, From 2021-01-01 |
| 2020-12-31 | $54.62M | n/m | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | $1.86M | +35.3% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $1.37M | -67.2% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $4.19M | -77.0% | 2020-03-11, From 2017-01-01 |
| 2016-12-31 | $18.20M | -0.4% | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | $18.27M | +151.3% | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | $7.27M | +25.6% | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $5.79M | +33.3% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $4.34M | +611.6% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $610.0K | -60.8% | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | $1.56M | +108.9% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $745.0K | n/a | 2012-03-14, From 2009-01-01 |